Kanagawa, Japan

Naoki Yamada

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Liposome Production. Top assignees: Fujifilm Corporation, Sony Corporation, Komatsu Electronic Metals Co., Ltd.. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Yamada. Retrieved from https://idiyas.com/inventor/naoki-yamada-70edoxlj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 72.7

 


Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 124(Granted Patents)


Location History:

  • Miyazaki, JP (1998 - 2002)
  • Yokohama, JP (1999 - 2009)
  • Osaka, JP (2009 - 2010)
  • Ashigarakami-gun, JP (2022)
  • Kanagawa, JP (1996 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Liposome Composition
Pharmaceutical Composition
Laser Processing
Debris Extraction
Semiconductor Device
Display Panel
Memory Macros
Liquid Crystal Display
Semiconductor Wafer
Polishing Cloth
Microlens Arrays
22 patents (USPTO):Explore Patents

Title: A Spotlight on Naoki Yamada: Innovations in Liposome Production

Introduction: Naoki Yamada is a prominent inventor based in Kanagawa, Japan, recognized for his significant contributions in the field of liposome technology. With a remarkable portfolio of 22 patents, Yamada's work focuses primarily on methods and apparatuses designed for liposome production. His inventions not only enhance production efficiency but also improve the pharmaceutical applications of liposomes.

Latest Patents: Yamada's latest innovations include two essential patents: the "Method for Producing Liposome" and the "Apparatus for Producing Liposome." The method entails a process for generating miniaturized liposomes on a large scale. This process involves stirring a mixture of lipid-dissolved oil phase and water phase within a specialized apparatus. Key parameters include a circulation path capacity ratio of 0.4 or less and a return time to the first tank of no more than 2.0 minutes. Additionally, his patent on "Liposome Composition and Pharmaceutical Composition" aims to provide formulations with high area under the curve (AUC) values. This innovation features a liposome composition enriched with a hydrophilic polymer-modified diacylphosphatidylethanolamine, dihydrosphingomyelin, and cholesterol, designed to encapsulate drugs effectively.

Career Highlights: Throughout his career, Naoki Yamada has held influential roles within esteemed organizations such as Sony Corporation and Fujifilm Corporation. His expertise and innovative mindset have been pivotal in advancing pharmaceutical formulations and production methodologies in the field of liposome technology.

Collaborations: Yamada's journey in innovation has been complemented by collaborations with notable professionals, including Hidehisa Murase and Yoshinari Sasaki. These partnerships have fostered a dynamic exchange of ideas and advanced the development of liposome-based applications.

Conclusion: Naoki Yamada stands as a trailblazer in liposome innovation, with a robust patent portfolio reflecting his dedication to enhancing pharmaceutical technologies. His latest patents reveal a commitment to improving production methods and compositions, which could have a significant impact on drug delivery systems in the near future. With every invention, Yamada continues to push the boundaries of scientific discovery and application in the biotechnology field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…